Cargando…

Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation

The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Tingjuan, Hu, Boli, Wang, Xingbo, Lin, Lulu, Zhou, Jianwei, Xu, Yuting, Yan, Yan, Zheng, Xiaojuan, Zhou, Jiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125067/
https://www.ncbi.nlm.nih.gov/pubmed/33975961
http://dx.doi.org/10.1128/mSystems.00016-21
_version_ 1783693391305900032
author Deng, Tingjuan
Hu, Boli
Wang, Xingbo
Lin, Lulu
Zhou, Jianwei
Xu, Yuting
Yan, Yan
Zheng, Xiaojuan
Zhou, Jiyong
author_facet Deng, Tingjuan
Hu, Boli
Wang, Xingbo
Lin, Lulu
Zhou, Jianwei
Xu, Yuting
Yan, Yan
Zheng, Xiaojuan
Zhou, Jiyong
author_sort Deng, Tingjuan
collection PubMed
description The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA5-induced beta interferon (IFN-β) expression by blocking IRF3 activation. Binding domain mapping showed that the CC1 domain of VP3 and the residue lysine-155 of tumor necrosis factor receptor-associated factor 3 (TRAF3) are essential for the interaction. Furthermore, we found that the CC1 domain was required for VP3 to downregulate MDA5-mediated IFN-β production. A ubiquitination assay showed that lysine-155 of TRAF3 was the critical residue for K33-linked polyubiquitination, which contributes to the formation of a TRAF3-TBK1 complex. Subsequently, we revealed that VP3 blocked TRAF3-TBK1 complex formation through reducing K33-linked polyubiquitination of lysine-155 on TRAF3. Taken together, our data reveal that VP3 inhibits MDA5-dependent IRF3-mediated signaling via blocking TRAF3-TBK1 complex formation, which improves our understanding of the interplay between RNA virus infection and the innate host antiviral immune response. IMPORTANCE Type I interferon plays a critical role in the host response against virus infection, including Avibirnavirus. However, many viruses have developed multiple strategies to antagonize the innate host antiviral immune response during coevolution with the host. In this study, we first identified that K33-linked polyubiquitination of lysine-155 of TRAF3 enhances the interaction with TBK1, which positively regulates the host IFN immune response. Meanwhile, we discovered that the interaction of the CC1 domain of the Avibirnavirus VP3 protein and the residue lysine-155 of TRAF3 reduced the K33-linked polyubiquitination of TRAF3 and blocked the formation of the TRAF3-TBK1 complex, which contributed to the downregulation of host IFN signaling, supporting viral replication.
format Online
Article
Text
id pubmed-8125067
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-81250672021-06-09 Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation Deng, Tingjuan Hu, Boli Wang, Xingbo Lin, Lulu Zhou, Jianwei Xu, Yuting Yan, Yan Zheng, Xiaojuan Zhou, Jiyong mSystems Research Article The host innate immune system develops various strategies to antagonize virus infection, and the pathogen subverts or evades host innate immunity for self-replication. In the present study, we discovered that Avibirnavirus infectious bursal disease virus (IBDV) VP3 protein significantly inhibits MDA5-induced beta interferon (IFN-β) expression by blocking IRF3 activation. Binding domain mapping showed that the CC1 domain of VP3 and the residue lysine-155 of tumor necrosis factor receptor-associated factor 3 (TRAF3) are essential for the interaction. Furthermore, we found that the CC1 domain was required for VP3 to downregulate MDA5-mediated IFN-β production. A ubiquitination assay showed that lysine-155 of TRAF3 was the critical residue for K33-linked polyubiquitination, which contributes to the formation of a TRAF3-TBK1 complex. Subsequently, we revealed that VP3 blocked TRAF3-TBK1 complex formation through reducing K33-linked polyubiquitination of lysine-155 on TRAF3. Taken together, our data reveal that VP3 inhibits MDA5-dependent IRF3-mediated signaling via blocking TRAF3-TBK1 complex formation, which improves our understanding of the interplay between RNA virus infection and the innate host antiviral immune response. IMPORTANCE Type I interferon plays a critical role in the host response against virus infection, including Avibirnavirus. However, many viruses have developed multiple strategies to antagonize the innate host antiviral immune response during coevolution with the host. In this study, we first identified that K33-linked polyubiquitination of lysine-155 of TRAF3 enhances the interaction with TBK1, which positively regulates the host IFN immune response. Meanwhile, we discovered that the interaction of the CC1 domain of the Avibirnavirus VP3 protein and the residue lysine-155 of TRAF3 reduced the K33-linked polyubiquitination of TRAF3 and blocked the formation of the TRAF3-TBK1 complex, which contributed to the downregulation of host IFN signaling, supporting viral replication. American Society for Microbiology 2021-05-11 /pmc/articles/PMC8125067/ /pubmed/33975961 http://dx.doi.org/10.1128/mSystems.00016-21 Text en Copyright © 2021 Deng et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Deng, Tingjuan
Hu, Boli
Wang, Xingbo
Lin, Lulu
Zhou, Jianwei
Xu, Yuting
Yan, Yan
Zheng, Xiaojuan
Zhou, Jiyong
Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title_full Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title_fullStr Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title_full_unstemmed Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title_short Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation
title_sort inhibition of antiviral innate immunity by avibirnavirus vp3 via blocking tbk1-traf3 complex formation and irf3 activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125067/
https://www.ncbi.nlm.nih.gov/pubmed/33975961
http://dx.doi.org/10.1128/mSystems.00016-21
work_keys_str_mv AT dengtingjuan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT huboli inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT wangxingbo inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT linlulu inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT zhoujianwei inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT xuyuting inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT yanyan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT zhengxiaojuan inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation
AT zhoujiyong inhibitionofantiviralinnateimmunitybyavibirnavirusvp3viablockingtbk1traf3complexformationandirf3activation